Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-17

Clinical Trial Update: Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.

View source ↗

Summary

This completed clinical trial investigates weight trajectory in patients with Type 2 Diabetes Mellitus who are new users of sulfonylureas added to metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfonylureas (class)

Snippet

Sponsor: Medical Research Foundation, The Netherlands | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED